Jude Gomila, CEO and Founder of Golden (formerly Recursion Inc.), is a pioneering figure at the intersection of technology and life sciences. With a focus on oncology, Gomila's strategic investments in Exogene and Cofactor Genomics showcase his commitment to advancing innovative solutions in cancer research and development. His visionary leadership continues to drive transformative change and push the boundaries of scientific exploration in the quest for improved cancer treatment and diagnosis.